Investigational Site Number 642001

Timișoara 300358

0 studies enrolling now · 2 studies all time

What they study most

Hematopoietic Neoplasm, Hypercholesterolemia

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) — Completed